246 related articles for article (PubMed ID: 34568091)
21. Abnormal expression of long non-coding RNA FGD5-AS1 affects the development of ovarian cancer through regulating miR-107/RBBP6 axis.
Zhang W; Shi J; Liu G
Chin J Physiol; 2023; 66(3):171-180. PubMed ID: 37322627
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
[TBL] [Abstract][Full Text] [Related]
23. Silencing of Long Noncoding RNA SOX21-AS1 Relieves Neuronal Oxidative Stress Injury in Mice with Alzheimer's Disease by Upregulating FZD3/5 via the Wnt Signaling Pathway.
Zhang L; Fang Y; Cheng X; Lian YJ; Xu HL
Mol Neurobiol; 2019 May; 56(5):3522-3537. PubMed ID: 30143969
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
25. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
Cui F; Luo P; Bai Y; Meng J
Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA ROR1-AS1 induces tumorigenesis of colorectal cancer by affecting Wnt/β-catenin signaling pathway.
Wang W; Zheng W; Zhang L; Li K
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693094
[TBL] [Abstract][Full Text] [Related]
28. Differential expression profiles of long noncoding RNAs and mRNAs in human bone marrow mesenchymal stem cells after exposure to a high dosage of dexamethasone.
Li T; Xu Y; Wang Y; Jiang Y
Stem Cell Res Ther; 2021 Jan; 12(1):9. PubMed ID: 33407832
[TBL] [Abstract][Full Text] [Related]
29. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell.
Yang Y; Li H; Hou S; Hu B; Liu J; Wang J
PLoS One; 2013; 8(5):e65309. PubMed ID: 23741487
[TBL] [Abstract][Full Text] [Related]
30. LncRNA FGD5-AS1 Promotes Abdominal Aortic Aneurysm Growth Through the Activation of MMP3 in Vascular Smooth Muscle Cells.
Xu Z; Lang D; Wang D; Hu S; Yang L
Int Heart J; 2023 May; 64(3):470-482. PubMed ID: 37197924
[TBL] [Abstract][Full Text] [Related]
31. Expression of lncRNA FGD5-AS1 correlates with poor prognosis in melanoma patients.
Gao Y; Zhu H; Mao Q
J Gene Med; 2020 Dec; 22(12):e3278. PubMed ID: 32997827
[TBL] [Abstract][Full Text] [Related]
32. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
Ye Y; Gu B; Wang Y; Shen S; Huang W
Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
[No Abstract] [Full Text] [Related]
33. LncRNA FGD5-AS1 can be predicted as therapeutic target in oral cancer.
Liu L; Zhan Y; Huang Y; Huang L
J Oral Pathol Med; 2020 Mar; 49(3):243-252. PubMed ID: 31899825
[TBL] [Abstract][Full Text] [Related]
34. Integrated network analysis to explore the key mRNAs and lncRNAs in acute myocardial infarction.
Shen LS; Hu XF; Chen T; Shen GL; Cheng D
Math Biosci Eng; 2019 Jul; 16(6):6426-6437. PubMed ID: 31698570
[TBL] [Abstract][Full Text] [Related]
35.
Zhang X; Gao Y; Zhang X; Zhang X; Xiang Y; Fu Q; Wang B; Xu Z
Front Cell Dev Biol; 2021; 9():630634. PubMed ID: 34046402
[TBL] [Abstract][Full Text] [Related]
36. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
Guan B; Ma J; Yang Z; Yu F; Yao J
Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
Liu CN; Zhang HY; Liu CL; Wang CC
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-induced lncRNA RBM5-AS1 promotes tumorigenesis via activating Wnt/β-catenin signaling in breast cancer.
Li X; Yang J; Ni R; Chen J; Zhou Y; Song H; Jin L; Pan Y
Cell Death Dis; 2022 Feb; 13(2):95. PubMed ID: 35110544
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/β-catenin pathway and associates with favorable prognosis of ovarian cancer.
Fu Y; Katsaros D; Biglia N; Wang Z; Pagano I; Tius M; Tiirikainen M; Rosser C; Yang H; Yu H
Sci Rep; 2021 Apr; 11(1):7484. PubMed ID: 33820921
[TBL] [Abstract][Full Text] [Related]
40. SH3PXD2A-AS1/miR-330-5p/UBA2 ceRNA network mediates the progression of colorectal cancer through regulating the activity of the Wnt/β-catenin signaling pathway.
Guo S; Zhu KX; Yu WH; Wang T; Li S; Wang YX; Zhang CC; Guo JQ
Environ Toxicol; 2021 Oct; 36(10):1969-1980. PubMed ID: 33073888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
